Plain-English translation of NCT07400926 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing a new version of an insertion tool (called the Model G2-TRIO) used to place a Travoprost implant into the eye. The implant is a tiny device that releases medication directly inside your eye to help manage glaucoma and high eye pressure. Researchers want to see how well this updated inserter works during the procedure.
Doctors are always looking for better ways to deliver glaucoma medications more effectively and safely. This trial will help determine whether the new inserter makes the procedure easier, safer, or more effective for patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive the glaucoma implant using the new Model G2-TRIO inserter device. The procedure involves placing a small medication implant inside your eye to help control eye pressure. Your eye doctor will monitor how well the new inserter works and how you respond to the treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.